IFNA21 ELISA Kits Search Results


elisa kit  (Wuhan Fine Biotech)
90
Wuhan Fine Biotech elisa kit
Elisa Kit, supplied by Wuhan Fine Biotech, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/elisa kit/product/Wuhan Fine Biotech
Average 90 stars, based on 1 article reviews
elisa kit - by Bioz Stars, 2026-04
90/100 stars
  Buy from Supplier
ifn l  (Thermo Fisher)
86
Thermo Fisher ifn l
Ifn L, supplied by Thermo Fisher, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/ifn l/product/Thermo Fisher
Average 86 stars, based on 1 article reviews
ifn l - by Bioz Stars, 2026-04
86/100 stars
  Buy from Supplier
sandwich enzyme linked immuno sorbent assay (elisa)  (Wuhan Fine Biotech)
90
Wuhan Fine Biotech sandwich enzyme linked immuno sorbent assay (elisa)
Sandwich Enzyme Linked Immuno Sorbent Assay (Elisa), supplied by Wuhan Fine Biotech, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/sandwich enzyme linked immuno sorbent assay (elisa)/product/Wuhan Fine Biotech
Average 90 stars, based on 1 article reviews
sandwich enzyme linked immuno sorbent assay (elisa) - by Bioz Stars, 2026-04
90/100 stars
  Buy from Supplier
ifn-α human verikinetm elisa kit  (PBL Assay)
90
PBL Assay ifn-α human verikinetm elisa kit
IFN-α, -β, -λ gene expression and protein release in MDM/TNF/IFNg, MDM/IL4 and MDM. MDM/TNF/IFNg, MDM/IL4 and MDM were treated with infectious RV16 or media alone and cells and supernatants were harvested at 8 h and 24 h or 72 h as indicated. Cell mRNA expression of IFN-α subtypes detected by primers pairs IFN-α.1 and IFN-α.2, panels (a) and (b) and mRNA expression of IFNB (c), IFN λ2/3 (d) and IFN λ1 (e) were measured by RT-PCR. Release of IFN-α (f), -β (g), -λ 1/3 (h), in supernatants was measured by <t>ELISA.</t> Data from three independent experiments with different donors; symbols show the mean of duplicate wells for each individual donor. Differences between multiple groups were analysed using one-way analysis of variance (ANOVA) with Tukey's post hoc test (horizontal bars and error bars are means + s .e.m. of the three donors). P-values from Tukey tests, where significant are shown on the graphs. NS = ANOVA not significant.
Ifn α Human Verikinetm Elisa Kit, supplied by PBL Assay, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/ifn-α human verikinetm elisa kit/product/PBL Assay
Average 90 stars, based on 1 article reviews
ifn-α human verikinetm elisa kit - by Bioz Stars, 2026-04
90/100 stars
  Buy from Supplier
human il-10 elisa ready-set-go!  (Thermo Fisher)
90
Thermo Fisher human il-10 elisa ready-set-go!
<t>IL-10,</t> MDC/CCL22 and TARC/CCL17 protein release from MDM/TNF/IFNg, MDM/IL4 and MDM with or without RV16 infection. MDM/TNF/IFNg, MDM/IL4 and MDM were infected with RV16 or treated with media alone and supernatants were harvested at the indicated time points. Release <t>of</t> <t>IL-10</t> (a), MDC (b) and TARC (c) in supernatants was measured by ELISA. Data from three independent experiments with different donors; symbols show the mean of duplicate wells for each individual donor. Differences between multiple groups were analysed using one-way analysis of variance (ANOVA) with Tukey's post hoc test (horizontal bars and error bars are means + s.e.m. of the three donors). P-values from Tukey tests, where significant are shown on the graphs. NS = ANOVA not significant.
Human Il 10 Elisa Ready Set Go!, supplied by Thermo Fisher, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/human il-10 elisa ready-set-go!/product/Thermo Fisher
Average 90 stars, based on 1 article reviews
human il-10 elisa ready-set-go! - by Bioz Stars, 2026-04
90/100 stars
  Buy from Supplier
human interferon alpha 21 (ifna21) elisa kit  (Bioss)
N/A
   Buy from Supplier
human interferon alpha-21(ifna21) elisa kit  (Cusabio)
N/A
Human Interferon alpha-21(IFNA21) ELISA kit
   Buy from Supplier

Image Search Results


IFN-α, -β, -λ gene expression and protein release in MDM/TNF/IFNg, MDM/IL4 and MDM. MDM/TNF/IFNg, MDM/IL4 and MDM were treated with infectious RV16 or media alone and cells and supernatants were harvested at 8 h and 24 h or 72 h as indicated. Cell mRNA expression of IFN-α subtypes detected by primers pairs IFN-α.1 and IFN-α.2, panels (a) and (b) and mRNA expression of IFNB (c), IFN λ2/3 (d) and IFN λ1 (e) were measured by RT-PCR. Release of IFN-α (f), -β (g), -λ 1/3 (h), in supernatants was measured by ELISA. Data from three independent experiments with different donors; symbols show the mean of duplicate wells for each individual donor. Differences between multiple groups were analysed using one-way analysis of variance (ANOVA) with Tukey's post hoc test (horizontal bars and error bars are means + s .e.m. of the three donors). P-values from Tukey tests, where significant are shown on the graphs. NS = ANOVA not significant.

Journal: EBioMedicine

Article Title: M1-like macrophages are potent producers of anti-viral interferons and M1-associated marker-positive lung macrophages are decreased during rhinovirus-induced asthma exacerbations

doi: 10.1016/j.ebiom.2020.102734

Figure Lengend Snippet: IFN-α, -β, -λ gene expression and protein release in MDM/TNF/IFNg, MDM/IL4 and MDM. MDM/TNF/IFNg, MDM/IL4 and MDM were treated with infectious RV16 or media alone and cells and supernatants were harvested at 8 h and 24 h or 72 h as indicated. Cell mRNA expression of IFN-α subtypes detected by primers pairs IFN-α.1 and IFN-α.2, panels (a) and (b) and mRNA expression of IFNB (c), IFN λ2/3 (d) and IFN λ1 (e) were measured by RT-PCR. Release of IFN-α (f), -β (g), -λ 1/3 (h), in supernatants was measured by ELISA. Data from three independent experiments with different donors; symbols show the mean of duplicate wells for each individual donor. Differences between multiple groups were analysed using one-way analysis of variance (ANOVA) with Tukey's post hoc test (horizontal bars and error bars are means + s .e.m. of the three donors). P-values from Tukey tests, where significant are shown on the graphs. NS = ANOVA not significant.

Article Snippet: IFN-α, IFN-β, IFN-λ1/3, CCL22/MDC, CCL17/TARC, CCL18/PARC and IL-10 proteins were quantified by enzyme-linked immunosorbent assay (ELISA) in supernatants collected and stored at −80 °C using commercially available paired antibodies and standards, following the manufacturer's instructions using the IFN-α human VeriKineTM ELISA kit (PBL Assay Science Inc.) detecting all human IFN-α subtypes except IFN-αF encoded by gene IFNA21 , human IFN-β ELISA kit (FUJIREBIO INC.), human IL-10 ELISA Ready-Set-Go! (eBioscience), human CCL22/MDC, human IL-29/IL-28B (IFN-λ1/3), human CCL17/TARC and human CCL18/PARC DuoSets ELISA kits (R&D Systems).

Techniques: Gene Expression, Expressing, Reverse Transcription Polymerase Chain Reaction, Enzyme-linked Immunosorbent Assay

IL-10, MDC/CCL22 and TARC/CCL17 protein release from MDM/TNF/IFNg, MDM/IL4 and MDM with or without RV16 infection. MDM/TNF/IFNg, MDM/IL4 and MDM were infected with RV16 or treated with media alone and supernatants were harvested at the indicated time points. Release of IL-10 (a), MDC (b) and TARC (c) in supernatants was measured by ELISA. Data from three independent experiments with different donors; symbols show the mean of duplicate wells for each individual donor. Differences between multiple groups were analysed using one-way analysis of variance (ANOVA) with Tukey's post hoc test (horizontal bars and error bars are means + s.e.m. of the three donors). P-values from Tukey tests, where significant are shown on the graphs. NS = ANOVA not significant.

Journal: EBioMedicine

Article Title: M1-like macrophages are potent producers of anti-viral interferons and M1-associated marker-positive lung macrophages are decreased during rhinovirus-induced asthma exacerbations

doi: 10.1016/j.ebiom.2020.102734

Figure Lengend Snippet: IL-10, MDC/CCL22 and TARC/CCL17 protein release from MDM/TNF/IFNg, MDM/IL4 and MDM with or without RV16 infection. MDM/TNF/IFNg, MDM/IL4 and MDM were infected with RV16 or treated with media alone and supernatants were harvested at the indicated time points. Release of IL-10 (a), MDC (b) and TARC (c) in supernatants was measured by ELISA. Data from three independent experiments with different donors; symbols show the mean of duplicate wells for each individual donor. Differences between multiple groups were analysed using one-way analysis of variance (ANOVA) with Tukey's post hoc test (horizontal bars and error bars are means + s.e.m. of the three donors). P-values from Tukey tests, where significant are shown on the graphs. NS = ANOVA not significant.

Article Snippet: IFN-α, IFN-β, IFN-λ1/3, CCL22/MDC, CCL17/TARC, CCL18/PARC and IL-10 proteins were quantified by enzyme-linked immunosorbent assay (ELISA) in supernatants collected and stored at −80 °C using commercially available paired antibodies and standards, following the manufacturer's instructions using the IFN-α human VeriKineTM ELISA kit (PBL Assay Science Inc.) detecting all human IFN-α subtypes except IFN-αF encoded by gene IFNA21 , human IFN-β ELISA kit (FUJIREBIO INC.), human IL-10 ELISA Ready-Set-Go! (eBioscience), human CCL22/MDC, human IL-29/IL-28B (IFN-λ1/3), human CCL17/TARC and human CCL18/PARC DuoSets ELISA kits (R&D Systems).

Techniques: Infection, Enzyme-linked Immunosorbent Assay

IL-10, MDC/CCL22 and TARC/CCL17 protein release from MDM/TNF/IFNg, MDM/IL4 and MDM with or without RV16 infection. MDM/TNF/IFNg, MDM/IL4 and MDM were infected with RV16 or treated with media alone and supernatants were harvested at the indicated time points. Release of IL-10 (a), MDC (b) and TARC (c) in supernatants was measured by ELISA. Data from three independent experiments with different donors; symbols show the mean of duplicate wells for each individual donor. Differences between multiple groups were analysed using one-way analysis of variance (ANOVA) with Tukey's post hoc test (horizontal bars and error bars are means + s.e.m. of the three donors). P-values from Tukey tests, where significant are shown on the graphs. NS = ANOVA not significant.

Journal: EBioMedicine

Article Title: M1-like macrophages are potent producers of anti-viral interferons and M1-associated marker-positive lung macrophages are decreased during rhinovirus-induced asthma exacerbations

doi: 10.1016/j.ebiom.2020.102734

Figure Lengend Snippet: IL-10, MDC/CCL22 and TARC/CCL17 protein release from MDM/TNF/IFNg, MDM/IL4 and MDM with or without RV16 infection. MDM/TNF/IFNg, MDM/IL4 and MDM were infected with RV16 or treated with media alone and supernatants were harvested at the indicated time points. Release of IL-10 (a), MDC (b) and TARC (c) in supernatants was measured by ELISA. Data from three independent experiments with different donors; symbols show the mean of duplicate wells for each individual donor. Differences between multiple groups were analysed using one-way analysis of variance (ANOVA) with Tukey's post hoc test (horizontal bars and error bars are means + s.e.m. of the three donors). P-values from Tukey tests, where significant are shown on the graphs. NS = ANOVA not significant.

Article Snippet: IFN-α, IFN-β, IFN-λ1/3, CCL22/MDC, CCL17/TARC, CCL18/PARC and IL-10 proteins were quantified by enzyme-linked immunosorbent assay (ELISA) in supernatants collected and stored at −80 °C using commercially available paired antibodies and standards, following the manufacturer's instructions using the IFN-α human VeriKine™ ELISA kit (PBL Assay Science Inc.) detecting all human IFN-α subtypes except IFN-αF encoded by gene IFNA21 , human IFN-β ELISA kit (FUJIREBIO INC.), human IL-10 ELISA Ready-Set-Go! (eBioscience), human CCL22/MDC, human IL-29/IL-28B (IFN-λ1/3), human CCL17/TARC and human CCL18/PARC DuoSets ELISA kits (R&D Systems).

Techniques: Infection, Enzyme-linked Immunosorbent Assay